Highlights

• Integrated Research (ASX:IRI) closed at AUD 0.32 on 18 August 2026, up 10.34%.
• S&P/ASX 200 Info Tech (ASX:XIJ) closed at 1,956.80 points, down 1.02% today.
• FY26 Revenue guidance range was AUD 56 million–AUD 58 million.
• Cash balance increased to AUD 51.7 million at 30 June 2026.

Integrated Research Limited (ASX:IRI) closed at AUD 0.32 on 18 August 2026, increasing 10.34% during the trading session. The movement occurred during a weaker session for technology stocks, with investors assessing the company’s observability software platform, product-led growth strategy and FY27 priorities.

The broader Australian market recorded lower trading levels, with the S&P/ASX 200 (ASX:XJO) closing at 9,070.00 points, down 0.035% today, while the S&P/ASX 300 (ASX:XKO) closed at 9,004.90 points, down 0.037% today.

The S&P/ASX 200 Info Tech (ASX:XIJ) closed at 1,956.80 points, down 1.02% today.

A daily share price movement does not necessarily indicate a change in a company’s underlying fundamentals. Investors generally assess software adoption, renewal activity, new customer contribution, product development, cash position and execution of strategic priorities when reviewing technology companies.

Enterprise observability software platform

Integrated Research provides observability solutions for business-critical IT ecosystems through its Prognosis platform.

The company’s technology supports organisations managing complex IT environments, including unified communications, customer experience platforms, payments infrastructure and multi-vendor technology systems.

Prognosis provides real-time monitoring and analytics capabilities designed to help enterprises identify operational issues, improve system performance and manage technology environments.

Integrated Research’s Business model includes software licences, subscriptions, maintenance agreements and support services. The company has been transitioning towards product-led growth, with greater focus on recurring software revenue and monetisation of newer products.

Investors generally monitor Integrated Research through renewal performance, new customer wins, subscription adoption, product development, margins and cash generation.

FY26 update and product-led growth strategy

Integrated Research released its FY26 Results Trading Update on 24 July 2026, reporting unaudited FY26 revenue guidance of AUD 56 million to AUD 58 million, compared with FY25 revenue of AUD 68.3 million. The company stated that revenue performance was affected by a softer renewals book and lower second-half new business contribution.

The company reported FY26 pro forma revenue guidance of AUD 64 million to AUD 66 million, compared with AUD 74.3 million in FY25. Pro forma revenue adjusts term licence fee revenue to reflect subscription-based recognition over the contract period.

Integrated Research guided to FY26 EBITDA between a loss of AUD 2.0 million and AUD 4.0 million, compared with EBITDA of AUD 15.9 million in FY25. The company noted that full-year Earnings were impacted by expected Credit losses and foreign exchange movements.

The company maintained a strong cash position, reporting cash of AUD 51.7 million at 30 June 2026, up from AUD 40.6 million at 30 June 2025. Integrated Research stated that the cash position would support continued Investment in product-led growth initiatives.

Management identified product monetisation and client-led innovation as key priorities for FY27. The company highlighted artificial intelligence as influencing technology investment decisions, with a focus on accelerating adoption of new products and expanding customer innovation programs.

Integrated Research’s Prognosis platform continues to support large global organisations requiring real-time visibility across complex IT environments. The company has more than 30 years of experience in enterprise observability and continues focusing on improving product capability.

Factors investors generally monitor

For Integrated Research, renewal performance remains a key operating measure. The company’s revenue base includes software agreements that require ongoing customer retention and contract renewals.

New business growth is another important consideration. Investors monitor whether new customer wins and product adoption can offset revenue changes from existing contracts.

Product-led growth is central to the company’s strategy. Investors assess whether investments in newer products translate into additional revenue opportunities and improved customer engagement.

Artificial intelligence adoption is also becoming an important area of focus. Investors monitor how AI-related technology changes influence customer spending decisions and Demand for observability solutions.

Cash management remains a key consideration. Integrated Research’s cash position provides flexibility for product investment, but investors continue assessing the balance between investment and revenue generation.

Enterprise technology spending cycles are another factor. Large organisations may adjust technology investment timing depending on economic conditions and strategic priorities.

Understanding the share price movement

Integrated Research shares increased 10.34% on 18 August 2026, reflecting trading activity during the session. Short-term share price movements can occur due to investor sentiment, technology sector trends, market positioning and expectations around future performance.

A single trading day’s movement does not independently confirm a change in the company’s operational performance or financial outlook. Investors generally review renewal trends, product adoption, customer activity, margins and strategic execution when assessing software businesses.

For Integrated Research, investor attention remains focused on returning to sustainable revenue growth through product innovation and customer-led expansion.

Enterprise software sector outlook

The enterprise software sector continues evolving as organisations seek improved visibility, automation and reliability across increasingly complex technology environments.

Observability providers are generally assessed on their ability to support critical systems, integrate with multiple platforms and provide measurable operational benefits.

Integrated Research’s focus on Prognosis and product-led growth positions the company within a market where enterprises continue investing in technology resilience. However, performance remains influenced by customer renewal cycles, new business conversion, technology spending conditions and execution of product initiatives.

Future investor focus is likely to remain on revenue stabilisation, product monetisation, AI-related opportunities, renewal performance and progress against FY27 priorities.

Conclusion

Integrated Research (ASX:IRI) closed at AUD 0.32 on 18 August 2026, up 10.34% during the session. The company continues developing its observability software platform for enterprise IT environments through Prognosis and product-led growth initiatives.

The FY26 trading update highlighted revenue guidance of AUD 56 million to AUD 58 million, pro forma revenue guidance of AUD 64 million to AUD 66 million and cash of AUD 51.7 million at 30 June 2026. While daily share price movements reflect market activity, they do not alone indicate changes in underlying business fundamentals. Investors continue to monitor renewal performance, product monetisation, customer adoption and execution of FY27 growth priorities.